LRRK2 and Parkinson disease: Since GBA mutations are linked to reduced GCase activity and more aggressive PD pathology, it was hypothesised LRRK2 mutations could have a protective effect on GBA mutation carriers through a mechanism that still remains unknown (Alcalay et al., 2015).